Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Oxygen Therapy for BP Stability in SCI
NCT06691165Phase 2Recruiting
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in spinal cord injury (SCI). Primary endpoint: Change in 24-hour mean arterial blood pressure. Started Oct 2025; status: recruiting.
02
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT06691165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06691165.